EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Treatment with a self-expanding endoprosthesis in patients with stenosis or occlusion at the arteriovenous graft: 6-Month outcomes of a post-marketing surveillance study

Hiroaki Haruguchi iD, Mizuya Fukasawa, Kiyoshi Ikeda, Kotaro Suemitsu iD, Takashi Sato, Masahito Miyamoto, Masaaki Murakami iD, Junichi Nakamura, Tomonaga Noguchi, Daihiko Eguchi, Taro Kamimura, Kiyoshi Aikawa

The Journal of Vascular Access · 2025

DOI: 10.1177/11297298241286249 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Hiroaki Haruguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Haruguchi Vascular Access Clinic, Tokyo, Japan. Hauptthemen laut MEDLINE: Graft Occlusion, Vascular, Arteriovenous Shunt, Surgical, Blood Vessel Prosthesis Implantation, Blood Vessel Prosthesis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: W. L. Gore and Associates.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess 6-month safety and efficacy of a self-expanding stent graft placement to treat stenotic or thrombosed synthetic arteriovenous access graft at the venous anastomoses. Material and methods: This prospective, multicenter, post-market surveillance study assessed the GORE ® VIABAHN ® Endoprosthesis (stent graft) in Japanese patients with stenotic or thrombosed vascular access grafts. Key efficacy and safety outcomes were primary patency (PP) and secondary patency (SP) of the target lesion and the vascular access circuit, repeat interventions, technical and clinical success, incidence of adverse and serious adverse events, and device deficiencies through 6 months.

Results

The 103 enrolled patients (mean age 71.8 years; 57.3% female) had stent grafts placed in the venous anastomosis of arteriovenous access grafts (on-label). The majority of lesions were stenotic (77.1%) and located in the upper arm (91.4%). Mean lesion length was 42.9 ± 23.6 mm and diameter was 6.7 ± 1.9 mm; 28 patients (27.2%) had elephant trunk placements. Technical and clinical success rates were 100%. At 6 months, Kaplan-Meier estimates of target lesion and circuit PP were 75.1% (95% CI: 65.2, 82.6) and 66.8% (95% CI: 56.4, 75.3), and SP rates were 93.8% (95% CI: 86.7, 97.2) and 93.8% (95% CI: 86.7, 97.2), respectively. Mean cumulative number of reinterventions (0.36; 95% CI: 0.20, 0.51) and incidence of device- or procedure-related adverse events were low (⩽3%). No device deficiencies were reported.

Conclusions

The 6-month outcomes of the self-expanding stent graft to treat thrombosed venous anastomoses of synthetic hemodialysis vascular access grafts with stenosis demonstrated safety and effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft Occlusion, VascularArteriovenous Shunt, SurgicalBlood Vessel Prosthesis ImplantationBlood Vessel ProsthesisRenal DialysisThrombosisEndovascular ProceduresHumansFemaleAgedVascular PatencyMaleProspective StudiesProduct Surveillance, PostmarketingTime FactorsProsthesis DesignTreatment OutcomeJapanMiddle AgedAged, 80 and overRisk Factors

Stichwörter der Autor:innen

Arteriovenous graftGORE® VIABAHN® Endoprosthesisarteriovenous accesshemodialysis vascular accessself-expanding stent graftvenous anastomoses

Autor:innen und Institutionen

  • Haruguchi Vascular Access Clinic, Tokyo, Japan.
  • Kanoiwa General Hospital, Yamanashi, Japan.
  • Ikeda Vascular Access, Dialysis and Internal Medicine Clinic, Fukuoka, Japan.
  • Kansai Rosai Hospital, Hyogo, Japan.
  • Kaikoukai Central Clinic, Aichi, Japan.
  • Yokohama Daiichi Hospital, Kanagawa, Japan.

ORCID-Profile: Hiroaki Haruguchi, Kotaro Suemitsu, Masaaki Murakami

Förderung

  • W. L. Gore and Associates

Zitieren

APA

Haruguchi, H., Fukasawa, M., Ikeda, K., Suemitsu, K., Sato, T., Miyamoto, M., Murakami, M., Nakamura, J., Noguchi, T., Eguchi, D., Kamimura, T., & Aikawa, K. (2025). Treatment with a self-expanding endoprosthesis in patients with stenosis or occlusion at the arteriovenous graft: 6-Month outcomes of a post-marketing surveillance study. The Journal of Vascular Access. https://doi.org/10.1177/11297298241286249

Vancouver

Haruguchi H, Fukasawa M, Ikeda K, Suemitsu K, Sato T, Miyamoto M, et al. Treatment with a self-expanding endoprosthesis in patients with stenosis or occlusion at the arteriovenous graft: 6-Month outcomes of a post-marketing surveillance study. The Journal of Vascular Access. 2025. doi:10.1177/11297298241286249

BibTeX
@article{Haruguchi2025,
  author = {Haruguchi, Hiroaki and Fukasawa, Mizuya and Ikeda, Kiyoshi and Suemitsu, Kotaro and Sato, Takashi and Miyamoto, Masahito and Murakami, Masaaki and Nakamura, Junichi and Noguchi, Tomonaga and Eguchi, Daihiko and Kamimura, Taro and Aikawa, Kiyoshi},
  title = {Treatment with a self-expanding endoprosthesis in patients with stenosis or occlusion at the arteriovenous graft: 6-Month outcomes of a post-marketing surveillance study},
  journal = {The Journal of Vascular Access},
  year = {2025},
  doi = {10.1177/11297298241286249}
}
Kostenlos starten →